Impact of genetic polymorphisms of the β2‐adrenergic receptor on albuterol bronchodilator pharmacodynamics View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-05

AUTHORS

John J. Lima, Donald B. Thomason, Mohamad H.N. Mohamed, Louis V. Eberle, Timothy H. Self, Julie A. Johnson

ABSTRACT

OBJECTIVE: To determine whether genetic polymorphisms of the beta2-adrenergic receptor gene affect the relationship between albuterol (INN, salbutamol) plasma concentrations and the forced expiratory volume in 1 second (FEV1) in subjects with moderate asthma. METHODS: Sixteen clinically stable patients with moderate asthma who participated in a pharmacokinetic-pharmacodynamic study of albuterol volunteered to provide a blood sample for determination of beta2-adrenergic receptor genotype. FEV1 and plasma concentrations of albuterol were determined at various times after administration of an oral solution that contained 8 mg albuterol. Patients withheld inhaled beta2-agonist and corticosteroid therapy 12 and 24 hours, respectively, before the study. beta2-Adrenergic receptor genotype was determined by polymerase chain reaction with allele-specific oligonucleotide hybridization. RESULTS: Albuterol-evoked FEV1 was higher and the response was more rapid in Arg16 homozygotes compared with the cohort of carriers of the Gly16 variant: Maximal percentage increase in FEV1 (%deltaFEV1), 18% versus 4.9% (P < .03); area under FEV1 albuterol concentration curve, 194%.mL/ng versus 30%.mL/ng (P < .05); initial slope (dE/dC), 1.43%.mL/ng versus 0.55%.mL/ng (P < .003). CONCLUSIONS: The beta2-adrenergic receptor gene polymorphism is a major determinant of bronchodilator response to albuterol. Future pharmacodynamic studies of beta2-agonists should include determination of 02-adrenergic receptor genotype. More... »

PAGES

519-525

References to SciGraph publications

  • 1990-04. Clinical Pharmacokinetics of β-Agonists in CLINICAL PHARMACOKINETICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1016/s0009-9236(99)70071-8

    DOI

    http://dx.doi.org/10.1016/s0009-9236(99)70071-8

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1013381298

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/10340917


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Cardiorespiratory Medicine and Haematology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adrenergic beta-Agonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Albuterol", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Arginine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Asthma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bronchodilator Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Forced Expiratory Volume", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genotype", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glycine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Polymerase Chain Reaction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Polymorphism, Genetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Adrenergic, beta-2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Severity of Illness Index", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn.", 
              "id": "http://www.grid.ac/institutes/grid.411461.7", 
              "name": [
                "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lima", 
            "givenName": "John J.", 
            "id": "sg:person.0636631252.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636631252.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn.", 
              "id": "http://www.grid.ac/institutes/grid.411461.7", 
              "name": [
                "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Thomason", 
            "givenName": "Donald B.", 
            "id": "sg:person.01227052427.71", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227052427.71"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn.", 
              "id": "http://www.grid.ac/institutes/grid.411461.7", 
              "name": [
                "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mohamed", 
            "givenName": "Mohamad H.N.", 
            "id": "sg:person.0676247342.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676247342.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn.", 
              "id": "http://www.grid.ac/institutes/grid.411461.7", 
              "name": [
                "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Eberle", 
            "givenName": "Louis V.", 
            "id": "sg:person.01141107032.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141107032.92"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn.", 
              "id": "http://www.grid.ac/institutes/grid.411461.7", 
              "name": [
                "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Self", 
            "givenName": "Timothy H.", 
            "id": "sg:person.0741264243.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741264243.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn.", 
              "id": "http://www.grid.ac/institutes/grid.411461.7", 
              "name": [
                "University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Johnson", 
            "givenName": "Julie A.", 
            "id": "sg:person.013232056354.66", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013232056354.66"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.2165/00003088-199018040-00002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012157379", 
              "https://doi.org/10.2165/00003088-199018040-00002"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1999-05", 
        "datePublishedReg": "1999-05-01", 
        "description": "OBJECTIVE: To determine whether genetic polymorphisms of the beta2-adrenergic receptor gene affect the relationship between albuterol (INN, salbutamol) plasma concentrations and the forced expiratory volume in 1 second (FEV1) in subjects with moderate asthma.\nMETHODS: Sixteen clinically stable patients with moderate asthma who participated in a pharmacokinetic-pharmacodynamic study of albuterol volunteered to provide a blood sample for determination of beta2-adrenergic receptor genotype. FEV1 and plasma concentrations of albuterol were determined at various times after administration of an oral solution that contained 8 mg albuterol. Patients withheld inhaled beta2-agonist and corticosteroid therapy 12 and 24 hours, respectively, before the study. beta2-Adrenergic receptor genotype was determined by polymerase chain reaction with allele-specific oligonucleotide hybridization.\nRESULTS: Albuterol-evoked FEV1 was higher and the response was more rapid in Arg16 homozygotes compared with the cohort of carriers of the Gly16 variant: Maximal percentage increase in FEV1 (%deltaFEV1), 18% versus 4.9% (P < .03); area under FEV1 albuterol concentration curve, 194%.mL/ng versus 30%.mL/ng (P < .05); initial slope (dE/dC), 1.43%.mL/ng versus 0.55%.mL/ng (P < .003).\nCONCLUSIONS: The beta2-adrenergic receptor gene polymorphism is a major determinant of bronchodilator response to albuterol. Future pharmacodynamic studies of beta2-agonists should include determination of 02-adrenergic receptor genotype.", 
        "genre": "article", 
        "id": "sg:pub.10.1016/s0009-9236(99)70071-8", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2592230", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2423999", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1017409", 
            "issn": [
              "0009-9236", 
              "1532-6535"
            ], 
            "name": "Clinical Pharmacology & Therapeutics", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "65"
          }
        ], 
        "keywords": [
          "beta2-adrenergic receptor genotypes", 
          "receptor genotype", 
          "moderate asthma", 
          "plasma concentrations", 
          "beta2-adrenergic receptor gene polymorphisms", 
          "beta2-adrenergic receptor gene", 
          "albuterol plasma concentrations", 
          "cohort of carriers", 
          "mL/", 
          "genetic polymorphisms", 
          "pharmacokinetic-pharmacodynamic studies", 
          "maximal percentage increase", 
          "receptor gene polymorphisms", 
          "future pharmacodynamic studies", 
          "Arg16 homozygotes", 
          "expiratory volume", 
          "stable patients", 
          "bronchodilator response", 
          "polymerase chain reaction", 
          "\u03b22-adrenergic receptor", 
          "pharmacodynamic studies", 
          "blood samples", 
          "albuterol", 
          "gene polymorphisms", 
          "oral solution", 
          "FEV1", 
          "allele-specific oligonucleotide hybridization", 
          "chain reaction", 
          "receptor gene", 
          "asthma", 
          "patients", 
          "concentration curve", 
          "major determinant", 
          "percentage increase", 
          "polymorphism", 
          "oligonucleotide hybridization", 
          "genotypes", 
          "pharmacodynamics", 
          "cohort", 
          "administration", 
          "receptors", 
          "study", 
          "response", 
          "homozygotes", 
          "subjects", 
          "hours", 
          "concentration", 
          "determinants", 
          "variants", 
          "genes", 
          "increase", 
          "volume", 
          "hybridization", 
          "samples", 
          "carriers", 
          "relationship", 
          "time", 
          "impact", 
          "curves", 
          "initial slope", 
          "area", 
          "determination", 
          "reaction", 
          "slope", 
          "solution"
        ], 
        "name": "Impact of genetic polymorphisms of the \u03b22\u2010adrenergic receptor on albuterol bronchodilator pharmacodynamics", 
        "pagination": "519-525", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1013381298"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1016/s0009-9236(99)70071-8"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "10340917"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1016/s0009-9236(99)70071-8", 
          "https://app.dimensions.ai/details/publication/pub.1013381298"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:31", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_347.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1016/s0009-9236(99)70071-8"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(99)70071-8'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(99)70071-8'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(99)70071-8'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(99)70071-8'


     

    This table displays all metadata directly associated to this object as RDF triples.

    233 TRIPLES      21 PREDICATES      108 URIs      99 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1016/s0009-9236(99)70071-8 schema:about N2c6e269c7c1749b1b1466c64dadde50a
    2 N33504f3dc0684d1ebe55725964bba77b
    3 N366627d0cc124f5f938d8e0eabaff6a4
    4 N3aebf569db4046b5b5dcc31ffa3e848b
    5 N3c4e5b67b918440599d1673f005c712a
    6 N52e3425a10de498ca31e0b4df57f9057
    7 N54a60d3249d1470a901524b04dcdc6c8
    8 N5d517f482c984789a85278cd2ebe43a1
    9 N5e13449b4f8f4872a4198398d355705c
    10 N6dcfc6031dcc4ff08add29414804ecbf
    11 Nc70b2803d06a46c8b73bc6388cabdb63
    12 Nec255a34ef854383b7da3a12e874d847
    13 Nf23f9269c39245519eee4be587e876f9
    14 Nf635b04dd2394bc1ba128b2686d05882
    15 Nf6597f08c45b424eb2f2a3c1e325f7cf
    16 Nfd48049224ca4e6b97c7d069025131c5
    17 anzsrc-for:11
    18 anzsrc-for:1102
    19 schema:author N3205364e66354107a247e0fac9b3279c
    20 schema:citation sg:pub.10.2165/00003088-199018040-00002
    21 schema:datePublished 1999-05
    22 schema:datePublishedReg 1999-05-01
    23 schema:description OBJECTIVE: To determine whether genetic polymorphisms of the beta2-adrenergic receptor gene affect the relationship between albuterol (INN, salbutamol) plasma concentrations and the forced expiratory volume in 1 second (FEV1) in subjects with moderate asthma. METHODS: Sixteen clinically stable patients with moderate asthma who participated in a pharmacokinetic-pharmacodynamic study of albuterol volunteered to provide a blood sample for determination of beta2-adrenergic receptor genotype. FEV1 and plasma concentrations of albuterol were determined at various times after administration of an oral solution that contained 8 mg albuterol. Patients withheld inhaled beta2-agonist and corticosteroid therapy 12 and 24 hours, respectively, before the study. beta2-Adrenergic receptor genotype was determined by polymerase chain reaction with allele-specific oligonucleotide hybridization. RESULTS: Albuterol-evoked FEV1 was higher and the response was more rapid in Arg16 homozygotes compared with the cohort of carriers of the Gly16 variant: Maximal percentage increase in FEV1 (%deltaFEV1), 18% versus 4.9% (P < .03); area under FEV1 albuterol concentration curve, 194%.mL/ng versus 30%.mL/ng (P < .05); initial slope (dE/dC), 1.43%.mL/ng versus 0.55%.mL/ng (P < .003). CONCLUSIONS: The beta2-adrenergic receptor gene polymorphism is a major determinant of bronchodilator response to albuterol. Future pharmacodynamic studies of beta2-agonists should include determination of 02-adrenergic receptor genotype.
    24 schema:genre article
    25 schema:isAccessibleForFree false
    26 schema:isPartOf Nf29d7f4d4fc94f11b5dc45862e638004
    27 Nfe1522a08eaa43cdbd533a39bfc55e16
    28 sg:journal.1017409
    29 schema:keywords Arg16 homozygotes
    30 FEV1
    31 administration
    32 albuterol
    33 albuterol plasma concentrations
    34 allele-specific oligonucleotide hybridization
    35 area
    36 asthma
    37 beta2-adrenergic receptor gene
    38 beta2-adrenergic receptor gene polymorphisms
    39 beta2-adrenergic receptor genotypes
    40 blood samples
    41 bronchodilator response
    42 carriers
    43 chain reaction
    44 cohort
    45 cohort of carriers
    46 concentration
    47 concentration curve
    48 curves
    49 determinants
    50 determination
    51 expiratory volume
    52 future pharmacodynamic studies
    53 gene polymorphisms
    54 genes
    55 genetic polymorphisms
    56 genotypes
    57 homozygotes
    58 hours
    59 hybridization
    60 impact
    61 increase
    62 initial slope
    63 mL/
    64 major determinant
    65 maximal percentage increase
    66 moderate asthma
    67 oligonucleotide hybridization
    68 oral solution
    69 patients
    70 percentage increase
    71 pharmacodynamic studies
    72 pharmacodynamics
    73 pharmacokinetic-pharmacodynamic studies
    74 plasma concentrations
    75 polymerase chain reaction
    76 polymorphism
    77 reaction
    78 receptor gene
    79 receptor gene polymorphisms
    80 receptor genotype
    81 receptors
    82 relationship
    83 response
    84 samples
    85 slope
    86 solution
    87 stable patients
    88 study
    89 subjects
    90 time
    91 variants
    92 volume
    93 β2-adrenergic receptor
    94 schema:name Impact of genetic polymorphisms of the β2‐adrenergic receptor on albuterol bronchodilator pharmacodynamics
    95 schema:pagination 519-525
    96 schema:productId N75b8d98640b64a14ac4206128cef5ba5
    97 N81b168c0e8174949a9844c124535dc3c
    98 Ndb2ec59c23a449d6bad6f40b5cc6c519
    99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013381298
    100 https://doi.org/10.1016/s0009-9236(99)70071-8
    101 schema:sdDatePublished 2022-10-01T06:31
    102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    103 schema:sdPublisher N1da1e4e221f0487cb611b5c1e9a9a123
    104 schema:url https://doi.org/10.1016/s0009-9236(99)70071-8
    105 sgo:license sg:explorer/license/
    106 sgo:sdDataset articles
    107 rdf:type schema:ScholarlyArticle
    108 N10f3b74ef2844a22b2b9126928fe80c5 rdf:first sg:person.0741264243.50
    109 rdf:rest N3e6dd4c0519041a6a62519c6e20d3b46
    110 N1da1e4e221f0487cb611b5c1e9a9a123 schema:name Springer Nature - SN SciGraph project
    111 rdf:type schema:Organization
    112 N2c6e269c7c1749b1b1466c64dadde50a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Adult
    114 rdf:type schema:DefinedTerm
    115 N3205364e66354107a247e0fac9b3279c rdf:first sg:person.0636631252.39
    116 rdf:rest Nb243eee80dc3406bac0b6eacb457eb9a
    117 N33504f3dc0684d1ebe55725964bba77b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Polymorphism, Genetic
    119 rdf:type schema:DefinedTerm
    120 N366627d0cc124f5f938d8e0eabaff6a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Receptors, Adrenergic, beta-2
    122 rdf:type schema:DefinedTerm
    123 N3aebf569db4046b5b5dcc31ffa3e848b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Severity of Illness Index
    125 rdf:type schema:DefinedTerm
    126 N3c4e5b67b918440599d1673f005c712a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Adrenergic beta-Agonists
    128 rdf:type schema:DefinedTerm
    129 N3e6dd4c0519041a6a62519c6e20d3b46 rdf:first sg:person.013232056354.66
    130 rdf:rest rdf:nil
    131 N52e3425a10de498ca31e0b4df57f9057 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Polymerase Chain Reaction
    133 rdf:type schema:DefinedTerm
    134 N54a60d3249d1470a901524b04dcdc6c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Asthma
    136 rdf:type schema:DefinedTerm
    137 N5d517f482c984789a85278cd2ebe43a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Genotype
    139 rdf:type schema:DefinedTerm
    140 N5e13449b4f8f4872a4198398d355705c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Female
    142 rdf:type schema:DefinedTerm
    143 N6dcfc6031dcc4ff08add29414804ecbf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Albuterol
    145 rdf:type schema:DefinedTerm
    146 N75b8d98640b64a14ac4206128cef5ba5 schema:name dimensions_id
    147 schema:value pub.1013381298
    148 rdf:type schema:PropertyValue
    149 N81b168c0e8174949a9844c124535dc3c schema:name doi
    150 schema:value 10.1016/s0009-9236(99)70071-8
    151 rdf:type schema:PropertyValue
    152 Nb243eee80dc3406bac0b6eacb457eb9a rdf:first sg:person.01227052427.71
    153 rdf:rest Nb5b7b217d4b04ee78f9a7a0e53cc9131
    154 Nb5b7b217d4b04ee78f9a7a0e53cc9131 rdf:first sg:person.0676247342.47
    155 rdf:rest Ne3ba9a5fe13b48fd94e61d04a8593db1
    156 Nc70b2803d06a46c8b73bc6388cabdb63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Glycine
    158 rdf:type schema:DefinedTerm
    159 Ndb2ec59c23a449d6bad6f40b5cc6c519 schema:name pubmed_id
    160 schema:value 10340917
    161 rdf:type schema:PropertyValue
    162 Ne3ba9a5fe13b48fd94e61d04a8593db1 rdf:first sg:person.01141107032.92
    163 rdf:rest N10f3b74ef2844a22b2b9126928fe80c5
    164 Nec255a34ef854383b7da3a12e874d847 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Humans
    166 rdf:type schema:DefinedTerm
    167 Nf23f9269c39245519eee4be587e876f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Arginine
    169 rdf:type schema:DefinedTerm
    170 Nf29d7f4d4fc94f11b5dc45862e638004 schema:volumeNumber 65
    171 rdf:type schema:PublicationVolume
    172 Nf635b04dd2394bc1ba128b2686d05882 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Forced Expiratory Volume
    174 rdf:type schema:DefinedTerm
    175 Nf6597f08c45b424eb2f2a3c1e325f7cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Bronchodilator Agents
    177 rdf:type schema:DefinedTerm
    178 Nfd48049224ca4e6b97c7d069025131c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Male
    180 rdf:type schema:DefinedTerm
    181 Nfe1522a08eaa43cdbd533a39bfc55e16 schema:issueNumber 5
    182 rdf:type schema:PublicationIssue
    183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    184 schema:name Medical and Health Sciences
    185 rdf:type schema:DefinedTerm
    186 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
    187 schema:name Cardiorespiratory Medicine and Haematology
    188 rdf:type schema:DefinedTerm
    189 sg:grant.2423999 http://pending.schema.org/fundedItem sg:pub.10.1016/s0009-9236(99)70071-8
    190 rdf:type schema:MonetaryGrant
    191 sg:grant.2592230 http://pending.schema.org/fundedItem sg:pub.10.1016/s0009-9236(99)70071-8
    192 rdf:type schema:MonetaryGrant
    193 sg:journal.1017409 schema:issn 0009-9236
    194 1532-6535
    195 schema:name Clinical Pharmacology & Therapeutics
    196 schema:publisher Springer Nature
    197 rdf:type schema:Periodical
    198 sg:person.01141107032.92 schema:affiliation grid-institutes:grid.411461.7
    199 schema:familyName Eberle
    200 schema:givenName Louis V.
    201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141107032.92
    202 rdf:type schema:Person
    203 sg:person.01227052427.71 schema:affiliation grid-institutes:grid.411461.7
    204 schema:familyName Thomason
    205 schema:givenName Donald B.
    206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227052427.71
    207 rdf:type schema:Person
    208 sg:person.013232056354.66 schema:affiliation grid-institutes:grid.411461.7
    209 schema:familyName Johnson
    210 schema:givenName Julie A.
    211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013232056354.66
    212 rdf:type schema:Person
    213 sg:person.0636631252.39 schema:affiliation grid-institutes:grid.411461.7
    214 schema:familyName Lima
    215 schema:givenName John J.
    216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636631252.39
    217 rdf:type schema:Person
    218 sg:person.0676247342.47 schema:affiliation grid-institutes:grid.411461.7
    219 schema:familyName Mohamed
    220 schema:givenName Mohamad H.N.
    221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676247342.47
    222 rdf:type schema:Person
    223 sg:person.0741264243.50 schema:affiliation grid-institutes:grid.411461.7
    224 schema:familyName Self
    225 schema:givenName Timothy H.
    226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741264243.50
    227 rdf:type schema:Person
    228 sg:pub.10.2165/00003088-199018040-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012157379
    229 https://doi.org/10.2165/00003088-199018040-00002
    230 rdf:type schema:CreativeWork
    231 grid-institutes:grid.411461.7 schema:alternateName University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn.
    232 schema:name University of Tennessee Departments of Clinical Pharmacy, Pharmaceutical Sciences, Physiology and Biophysics, and Medicine, Colleges of Pharmacy and Medicine Memphis Tenn.
    233 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...